Sinopharm Tech Holdings Limited (8156.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 94.2M |
| Enterprise Value | 119.32M |
| P/E Ratio | -7.39 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 2.5 |
| Price/Book Ratio | -1.14 |
| Enterprise/Revenue | 3.05 |
| Enterprise/EBITDA | -21.43 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 45.58M |
| Revenue/Share | 0.15 |
| Gross Profit | 6.42M |
| EBITDA | -6.94M |
| Net Income | -9.14M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 5.62M |
| Total Cash/Share | 0.02 |
| Total Debt | 30.73M |
| Total Debt/Equity | -0.66 |
| Current Ratio | 0.38 |
| Book Value Per Share | -0.17 |
Price History
| 52-Week Change | -26.23 |
| 52-Week High | 0.36 |
| 52-Week Low | 0.15 |
| Moving Average 50 Days | 0.19 |
| Moving Average 200 Days | 0.23 |
Statistics
| Average Volume | 12,356 |
| Shares Outstanding | 633.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 29, 2023 |
AD
